The prevalence of bipolar disorder in autoimmune disease: a systematic review and meta-analysis

Abstract

Background: At the end of the last century, genome-wide association studies revealed a significant genetic association between bipolar disorder and autoimmune diseases. Subsequently, the theory of immune pathogenesis of bipolar disorder gradually formed, and the research on autoimmune diseases and bipolar comorbidities began to extend to other diseases, but their correlation is still controversial. To explore the differences in the prevalence of bipolar disorder in patients with autoimmune disease and normal healthy people through meta-analysis, and to examine the relationship between bipolar disorder and autoimmune disease by reviewing the relevant literature. Methods: The Cochrane, PubMed, and Embase databases were searched by computer from the date of inception of the database to July 2020. The main topics of the search were based on common autoimmune diseases, including systemic lupus erythematosus, rheumatoid arthritis, psoriasis, multiple sclerosis, ulcerative colitis, Crohn's disease, ankylosing spondylitis, pemphigus, and Sjogren's syndrome. The databases were comprehensively searched for controlled studies regarding the prevalence of bipolar disorder in patients with autoimmune diseases. Review Manager 5.3 software was used for meta-analysis. Results: In total, 10 cohort and case control studies were included. From these, 16 control groups were extracted based on nine autoimmune diseases. The meta-analysis demonstrated that the incidence of bipolar disorder was significantly increased in patients with autoimmune disease compared to patients without autoimmune disease, [mean difference (MD) =1.54, 95% confidence interval (CI): 1.28-1.86, P<0.00001]. Also, in the meta-analysis based on five cross-sectional analyses (in which a total of five control groups were extracted based on five autoimmune diseases), the high comorbidity rate of autoimmune diseases and bipolar disorder was verified (MD =2.23, 95% CI: 1.62-3.07, P<0.00001). Conclusions: The prevalence of bipolar disorder is markedly higher in patients with autoimmune disease. Yet, more basic research is needed to verify the special significance of immune mechanisms in bipolar disorder.

Stigmatization in Patients With Psoriasis: A Mini Review

“…Patients with psoriasis may be affected in other organs, such as joint (6) and cardiovascular system (7). Moreover, patients with psoriasis are susceptible to a variety of psychiatric disorders, including depression, anxiety (8), bipolar mood disorder (9), personality disorder (10), and cognitive impairment (11). Psoriasis may place a heavy physical and psychological burden on patients, negatively affecting patients' health status, private lives, and professional careers (12).…”

Catalytic Antibodies in Bipolar Disorder: Serum IgGs Hydrolyze Myelin Basic Protein

“…A pro-inflammatory status, neuroinflammation, and high comorbidity with autoimmune disorders can become a biological background for the generation of catalytic antibodies in bipolar disorder. Thus, a meta-analysis of 34,633 patients in 2021 showed high comorbidity of bipolar and autoimmune diseases (95% CI, 1.62-3.07), as well as a significantly higher incidence of bipolar disorder among patients with AD, compared with patients without them (95% CI, 1.28-1.86) [57]. A reduced number of circulating regulatory T lymphocytes, which suppress erroneous immune responses, indicates immune/inflammatory imbalance in patients with BD [54,58].…”

Acute Mania and Catatonia in a Teenager Successfully Treated with Electroconvulsive Therapy and Diagnosed with Turner Syndrome and Bipolar Disorder

“…There is growing evidence that autoimmune processes could play a causative role in several neuropsychiatric disorders, including psychosis [27] and possibly bipolar disorder [28]. Girls with TS are also at increased risk of developing a wide range of autoimmune diseases, especially thyroid diseases, but also celiac disease, type 1 diabetes mellitus, rheumatoid diseases, and inflammatory bowel disease [1,29].…”